Back to top
more

BioTechne Corp (TECH)

(Delayed Data from NSDQ)

$54.64 USD

54.64
2,616,758

-0.24 (-0.44%)

Updated Aug 5, 2025 04:00 PM ET

After-Market: $54.63 -0.01 (-0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (143 out of 246)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Agenus (AGEN) in Focus: Stock Moves 7.6% Higher

by Zacks Equity Research

Agenus (AGEN) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

Zacks Equity Research

Intercept (ICPT) Catches Eye: Stock Jumps 8.4%

by Zacks Equity Research

Intercept (ICPT) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

Zacks Equity Research

Earnings Preview: Techne (TECH) Q4 Earnings Expected to Decline

by Zacks Equity Research

Techne (TECH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Is Techne (TECH) a Solid Growth Stock? 3 Reasons to Think " Yes "

by Zacks Equity Research

Techne (TECH) could produce exceptional returns because of its solid growth attributes.

Zacks Equity Research

REGN vs. TECH: Which Stock Is the Better Value Option?

by Zacks Equity Research

REGN vs. TECH: Which Stock Is the Better Value Option?

Zacks Equity Research

LGND or TECH: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

LGND vs. TECH: Which Stock Is the Better Value Option?

Zacks Equity Research

LGND vs. TECH: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

LGND vs. TECH: Which Stock Is the Better Value Option?

Zacks Equity Research

Techne (TECH) Tops Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Techne (TECH) delivered earnings and revenue surprises of 23.01% and 5.31%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Earnings Preview: Techne (TECH) Q3 Earnings Expected to Decline

by Zacks Equity Research

Techne (TECH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

REGN vs. TECH: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

REGN vs. TECH: Which Stock Is the Better Value Option?

Zacks Equity Research

Techne (TECH) Lags Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Techne (TECH) delivered earnings and revenue surprises of -5.26% and -3.50%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Techne (TECH) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Techne (TECH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

GILD vs. TECH: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

GILD vs. TECH: Which Stock Is the Better Value Option?

Zacks Equity Research

CELG vs. TECH: Which Stock Is the Better Value Option?

by Zacks Equity Research

CELG vs. TECH: Which Stock Is the Better Value Option?

Zacks Equity Research

Techne (TECH) Q1 Earnings Lag Estimates

by Zacks Equity Research

Techne (TECH) delivered earnings and revenue surprises of -0.93% and 1.77%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

New Strong Sell Stocks for August 15th

by Zacks Equity Research

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.

Zacks Equity Research

Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

by Zacks Equity Research

Sector ETF report for PBE

Zacks Equity Research

Techne (TECH) Q4 Earnings and Revenues Lag Estimates

by Zacks Equity Research

Techne (TECH) delivered earnings and revenue surprises of -4.58% and -3.20%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Can All-Line Growth Aid CVS Health's (CVS) Earnings in Q2?

by Zacks Equity Research

Within the Health Care Benefits segment, CVS Health (CVS) expects the government programs to go from strength to strength on the back of Medicare growth and major Medicaid wins.

Zacks Equity Research

What's in Store for Cardinal Health (CAH) in Q4 Earnings?

by Zacks Equity Research

Better-than-expected performance at Pharmaceutical and Medical segments are likely to aid Cardinal Health's (CAH) in Q4 earnings.

Zacks Equity Research

Henry Schein (HSIC) to Post Q2 Earnings: A Beat in Store?

by Zacks Equity Research

Henry Schein (HSIC) is working diligently to grow in the field of digital dentistry, globally.

Zacks Equity Research

Can Patient Wins Aid GW Pharmaceuticals (GWPH) Q2 Earnings?

by Zacks Equity Research

GW Pharmaceuticals (GWPH) is witnessing a solid new patient recruitment for Epidolex and a huge number of physicians are recommending the same in their prescriptions.

Zacks Equity Research

Can Bruker (BRKR) Q2 Earnings See BioSpin's Growth Revival?

by Zacks Equity Research

Bruker (BRKR) expects BioSpin to bode well for better organic growth in Q2.

Zacks Equity Research

CBM or TECH: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

CBM vs. TECH: Which Stock Is the Better Value Option?

Zacks Equity Research

Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

by Zacks Equity Research

Sector ETF report for PBE